The form ‘Delta Plus’ was created by changing the virus from delta to delta or ‘B1.617.2’, first identified in India. This form was responsible for the second wave of the epidemic.
New Delhi: The coronavirus is constantly changing its form and now new forms of it have been identified. The delta form responsible for the second wave of corona in India has now been transformed into ‘Delta Plus’ or YY1, which is a new challenge for scientists. Due to fears of this delta variant, it has reached the stage of re-imposition of restrictions in many countries of the world. Not only that, the second wave of corona in India has proved to be the most deadly.
The second wave came from ‘Delta’
The relief is that there is nothing to worry about in India as there are still very few cases of it in the country. The form ‘Delta Plus’ was created by changing the virus from delta to delta or ‘B1.617.2’, first identified in India. This form was responsible for the second wave of the epidemic.
While there is still no indication of how deadly the disease could be as a result of the new form of the virus, Delta Plus is opposed to the recently approved ‘monochromatic antibody cocktail’ treatment in India.
Spreads infection in cells
Binod Sakaria, a scientist at Delhi-based CSIR-Genomics and Integrative Biology (IGIB), tweeted on Sunday that the K417N conversion also caused the B1.617.2 variant, also known as AY.1. He said that this conversion took place in the spike protein of SARS-Covi-2, which helps the virus to enter and infect human cells.
Scaria wrote on Twitter, ‘There are still not many variants derived from K417N in India. Most of these sequences come from Europe, Asia and America. Scaria added that the conversion could also be related to resistance to the virus.
Push the ‘antibody cocktail’ test
Immunity expert Binita Bal said the new form of the virus pushed the ‘antibody cocktail’ test, but that doesn’t mean the virus is more contagious or it will make the disease more deadly. Vinita Bal, a teacher at the Indian Institute of Science Education and Research in Pune, said, “It would be important to test the ability of this new form to spread rapidly, or vice versa.”
He added that the quality and antibodies that protect cells from pathogens in a newly infected person are not expected to be affected by mutations. Respiratory specialist and medical researcher Anurag Agarwal supported Binita Baal’s view.
Read more: Corona Delta re-escalates tensions, many countries, including Britain, show toughness
CSIR-IGIB director Anurag Agarwal said, “There is no need to worry about this form of the virus in India right now.” He said those who have taken the full dose of the vaccine will need to test for the virus from their plasma to see if it is capable of transmitting the disease.